Cargando…
Empagliflozin suppresses urinary mitochondrial DNA copy numbers and interleukin-1β in type 2 diabetes patients
Sodium-glucose co-transporter 2 (SGLT2) inhibitors improve cardiovascular and renal outcomes in type 2 diabetes mellitus (T2DM) patients. However, the mechanisms by which SGLT2 inhibitors improve the clinical outcomes remain elusive. We evaluated whether empagliflozin, an SGLT2 inhibitor, ameliorate...
Autores principales: | Lee, Haekyung, Kim, Hyoungnae, Jeon, Jin Seok, Noh, Hyunjin, Park, Rojin, Byun, Dong Won, Kim, Hye Jeong, Suh, Kyoil, Park, Hyeong Kyu, Kwon, Soon Hyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646895/ https://www.ncbi.nlm.nih.gov/pubmed/36351983 http://dx.doi.org/10.1038/s41598-022-22083-6 |
Ejemplares similares
-
Effect of bariatric surgery on circulating and urinary mitochondrial DNA copy numbers in obesity with or without diabetes
por: Seo, Mihae, et al.
Publicado: (2020) -
IgA nephropathy is associated with elevated urinary mitochondrial DNA copy numbers
por: Yu, Byung Chul, et al.
Publicado: (2019) -
Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
por: Lee, Haekyung, et al.
Publicado: (2022) -
Effect of diabetes on exosomal miRNA profile in patients with obesity
por: Kim, Hyoshik, et al.
Publicado: (2020) -
Metformin inhibits chronic kidney disease‐induced DNA damage and senescence of mesenchymal stem cells
por: Kim, Hyoungnae, et al.
Publicado: (2021)